Literature DB >> 11267373

Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?

J Groetzner1, B M Meiser, J Schirmer, J Koglin, W vScheidt, V Klauss, P Cremer, H Reichenspurner, B Reichart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11267373     DOI： 10.1016/s0041-1345(01)01906-6

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

Review 1.  Surgical biology for the clinician: vascular effects of immunosuppression.

Authors:  Elissa Tepperman; Danny Ramzy; Jessica Prodger; Rohit Sheshgiri; Mitesh Badiwala; Heather Ross; Vivek Raoa
Journal:  Can J Surg       Date:  2010-02       Impact factor: 2.089

Review 2.  Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials.

Authors:  Luit Penninga; Christian H Møller; Finn Gustafsson; Daniel A Steinbrüchel; Christian Gluud
Journal:  Eur J Clin Pharmacol       Date:  2010-09-30       Impact factor: 2.953

3.  Longitudinal changes in kidney function following heart transplantation: Stanford experience.

Authors:  Adetokunbo A Taiwo; Kiran K Khush; Margaret R Stedman; Yuanchao Zheng; Jane C Tan
Journal:  Clin Transplant       Date:  2018-10-25       Impact factor: 2.863

4.  Temporal Changes on the Risks and Complications of Posttransplantion Diabetes Mellitus Following Cardiac Transplantation.

Authors:  Nadia Iannino; Amine Nasri; Agnès Räkel; Anique Ducharme; Kim Lachance; Normand Racine; Simon de Denus; Maxime Tremblay-Gravel; Annik Fortier; Michel White
Journal:  J Transplant       Date:  2018-11-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.